Atlas One · Host Biology · Scale 07 — System

Thyroid Cancer

Malignant thyroid tumors: papillary (BRAF V600E ~60%, RET/PTC fusions ~20%), follicular, medullary (RET mutation MEN2), and anaplastic; differentiated thyroid cancer treated with RAI and lenvatinib/sorafenib; RET-mutant MTC → selpercatinib; BRAF+ ATC → dabrafenib+trametinib.

Also known as: thyroid cancer, thyroid carcinoma, papillary thyroid carcinoma, medullary thyroid carcinoma, anaplastic thyroid carcinoma, differentiated thyroid cancer, PTC, MTC, ATC, DTC

Scale 07 — SystemScale
draftStatus
2026-06-06Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
thyroid-cancer

Thyroid Cancer

Malignant thyroid tumors: papillary (BRAF V600E ~60%, RET/PTC fusions ~20%), follicular, medullary (RET mutation MEN2), and anaplastic; differentiated thyroid cancer treated with RAI and lenvatinib/sorafenib; RET-mutant MTC → selpercatinib; BRAF+ ATC → dabrafenib+trametinib.

Entry Metadata

FieldValue
IDthyroid-cancer
NameThyroid Cancer
Statusdraft
Last reviewed2026-06-06
Atlas01-human
Scale07-system

Cross-Atlas Connections

connects-toBraf connects-toVegf connects-toMtor connects-toPd 1 connects-toRet connects-toIodine connects-toCalcitonin connects-toNeuroendocrine Tumors connects-toFap connects-toT Cytotoxic Cell

Sources